| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +57.14% | -2.69% | +0.21% | -2.89% | -0.38% | — |
| 14d | 7 | +57.14% | -5.80% | -0.41% | -5.39% | -8.64% | — |
| 30d | 7 | +71.43% | +2.02% | -1.35% | +3.37% | +0.84% | — |
| 60d | 7 | +42.86% | +6.66% | +0.12% | +6.54% | +10.78% | — |
| 90d | 7 | +71.43% | -7.03% | -1.40% | -5.63% | -13.86% | — |
| 180d | 7 | +42.86% | -4.75% | +6.87% | -11.62% | -20.51% | — |
| 1y | 7 | +57.14% | -21.81% | +15.97% | -37.77% | -42.88% | — |
| 2y | 7(6 pending) | +100.00% | +170.53% | +57.92% | +112.61% | +112.61% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 23,447 | $10.06 | $235.8K | 77,362 | Jun 29, 2026 | Jul 1, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 232,000 | — | — | 232,000 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,282 | $4.67 | $20.0K | 100,809 | Jun 25, 2025 | Jun 26, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 18,000 | — | — | 30,822 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 32,146 | $8.76 | $281.7K | 96,527 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 18,000 | $1.55 | $27.9K | 128,673 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 13,534 | $7.23 | $97.8K | 110,673 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 13,673 | $8.22 | $112.4K | 124,207 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 22,081 | $4.56 | $100.6K | 137,880 | Nov 29, 2024 | Dec 3, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 14,051 | $6.47 | $90.9K | 159,961 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 12,645 | $5.97 | $75.5K | 174,012 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Scientific Officer | 19,748 | $0.90 | $17.8K | 186,657 | Nov 28, 2023 | Nov 30, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 112,790 | — | — | 206,405 | Nov 26, 2023 | Nov 28, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Apr 28, 2023 | May 2, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 1,238 | $1.61 | $2.0K | 2,738 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,877 | — | — | 92,377 | Nov 28, 2022 | Nov 30, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Feb 28, 2022 | Mar 1, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Feb 3, 2022 | Feb 7, 2022 ↗ | View → |